LENZ Therapeutics, Inc. logo

LENZ Therapeutics, Inc.

LENZNASDAQ

LENZ Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Evert Schimmelpennink, with a market cap of $567.6M. As of Q3 2025, 102% of shares are held by 167 institutional investors, with RA CAPITAL MANAGEMENT, LLC as the largest holder at 14.65%.

CEOEvert Schimmelpennink
Market Cap$567.6M
Biotechnology
Healthcare
Country
United States of America

Overview

Overview of institutional ownership in LENZ as of Q3 2025 with a market cap of $1.3B

All Institutions

Institutions
167
Value Held
$1.4B
Shares Held
29.1M
Avg Position
$8.1M
Median Position
$551.6K

Hedge Funds

Hedge Funds
26
Value Held
$621.6M
Shares Held
13.3M
Avg Position
$23.9M
Median Position
$8.7M

Ownership Breakdown

Institutional (non-HF): 55.25%Institutional (non-HF)Hedge Funds: 46.78%Hedge FundsRetail & Other: -
Institutional (non-HF)
55.25%
$734.0M
Hedge Funds
46.78%
$621.6M
Retail & Other
-
-

Based on market cap of $1.3B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in LENZ as of Q3 2025

InstitutionPosition Value
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
$194.6M
2.42% of portfolio
Falcon Edge Capital LP logo
Falcon Edge Capital LP
Hedge FundMulti-Strategy
$168.3M
17.04% of portfolio
$123.8M
58.25% of portfolio
BlackRock, Inc. logo
BlackRock, Inc.
Institution
$68.6M
0.00% of portfolio
$62.0M
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$56.0M
0.01% of portfolio
Paradigm Biocapital Advisors LP logo
Paradigm Biocapital Advisors LP
Hedge FundLong/Short
$50.0M
1.48% of portfolio
$47.4M
69.77% of portfolio
$41.8M
1.65% of portfolio
RTW INVESTMENTS, LLC logo
RTW INVESTMENTS, LLC
Hedge FundSector
$40.2M
0.50% of portfolio

Net Capital Flow

Institutional buying and selling activity for LENZ in Q3 2025

Traded
+$225.0M
Buyers
122
Sellers
27
Total Bought
+$351.9M
Total Sold
$126.9M
Avg Position
$7.9M

Biggest Buyers

InstitutionNet Bought
+$123.8M
+2.7M shares
+$32.3M
+693.0K shares
+$26.9M
+578.5K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$18.2M
+390.4K shares
UBS Group AG logo
UBS Group AG
Institution
+$14.9M
+320.1K shares
+$13.1M
+281.2K shares
+$11.0M
+236.2K shares
P
PLUSTICK MANAGEMENT LLC
Hedge FundDistressed
+$9.3M
+200.0K shares
+$7.1M
+152.2K shares
N
Nuveen, LLC
Institution
+$5.0M
+107.3K shares

Biggest Sellers

InstitutionNet Sold
Paradigm Biocapital Advisors LP logo
Paradigm Biocapital Advisors LP
Hedge FundLong/Short
$30.0M
643.6K shares
$28.6M
977.2K shares
$23.1M
495.1K shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$13.5M
289.1K shares
Point72 Asset Management, L.P. logo
Point72 Asset Management, L.P.
Hedge FundMulti-Strategy
$13.0M
278.1K shares
Ally Bridge Group  LLC logo
Ally Bridge Group LLC
Hedge FundSector
$7.8M
168.0K shares
StemPoint Capital LP logo
StemPoint Capital LP
Hedge FundLong/Short
$5.4M
183.9K shares
$1.7M
35.4K shares
$882.5K
30.1K shares
LORD, ABBETT & CO. LLC logo
LORD, ABBETT & CO. LLC
Long Only Manager
$797.4K
17.1K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited LENZ in Q3 2025

New Positions
46
New Value
$191.9M
Exited Positions
4
Exited Value
$34.9M

New Positions

InstitutionPosition Value
$123.8M
2.7M shares
$32.3M
693.0K shares
P
PLUSTICK MANAGEMENT LLC
Hedge FundDistressed
$9.3M
200.0K shares
Tyro Capital Management LLC logo
Tyro Capital Management LLC
Hedge FundLong/Short
$4.7M
100.7K shares
$3.9M
84.0K shares
EAM Investors, LLC logo
EAM Investors, LLC
Long Only Manager
$3.7M
80.2K shares
$2.0M
43.8K shares
H
$1.4M
29.3K shares
$1.3M
28.3K shares
$1.1M
24.1K shares

Exited Positions

InstitutionPrevious Position
$28.6M
977.2K shares
StemPoint Capital LP logo
StemPoint Capital LP
Hedge FundLong/Short
$5.4M
183.9K shares
$882.5K
30.1K shares
$30.0
1.0 shares

Options Activity

Institutions with the largest Call and Put options positions in LENZ as of Q3 2025

Call Positions
4
Call Value
$1.8M
Put Positions
2
Put Value
$5.8M

Call Positions

InstitutionPosition Value
$833.8K
179.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$670.8K
144.0 contracts
$265.5K
57.0 contracts
Caption Management, LLC logo
Caption Management, LLC
Hedge FundLong/Short
-
- contracts

Put Positions

InstitutionPosition Value
$4.6M
994.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$1.2M
249.0 contracts

Most Committed Institutions

Institutions with LENZ as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
69.77%
$47.4M
58.25%
$123.8M
Falcon Edge Capital LP logo
Falcon Edge Capital LP
Hedge FundMulti-Strategy
17.04%
$168.3M
Ally Bridge Group  LLC logo
Ally Bridge Group LLC
Hedge FundSector
6.84%
$8.2M
S
SCOGGIN LLC
Hedge FundEvent Driven
4.19%
$10.5M
P
PLUSTICK MANAGEMENT LLC
Hedge FundDistressed
3.91%
$9.3M
3.76%
$17.1M
3.04%
$32.3M
RA CAPITAL MANAGEMENT, LLC logo
RA CAPITAL MANAGEMENT, LLC
Hedge FundLong/Short
2.42%
$194.6M
2.09%
$16.0M

Hedge Fund Spotlight

Discover hedge funds investing in LENZ

Portfolio ManagerNnamdi C Etoh
Portfolio Value
$1.7B
Positions
91
Last Reported
Q3 2025
AddressBaltimore, MD
Sector Allocation
Healthcare: 81.80%HealthcareETF: 0.90%
LENZ Therapeutics, Inc. logo

Position in LENZ Therapeutics, Inc.

Market Value
$11.0M
Shares Held
236.2K
Portfolio Weight
0.65%
Owned Since
2024-Q4
Top HoldingSectorMarket ValueWeight
1
ARGX
argenx
ARGX
Unknown
Unknown
$105.3M6.18%
Drug Manufacturers - General
Healthcare
$80.4M4.72%
Biotechnology
Healthcare
$72.4M4.25%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.